Delisting risk
Genprex (GNPX)
Develops REQORSA for lung cancer and GPX-002 for diabetes.
$3.51
Pre-market+0.01 (+0.29%)
At close$3.50(−1.41%)
Something off on this page? Send us feedback.
Breakdown13F · 13D/G · Form 4
| Institutions26 holders · as of Mar 31, 2026 | 0.52% | 4.2K shares | |
| Insiders5 holders · as of Apr 15, 2026 | 0.47% | 3.9K shares | |
| Otherremainder | 99.01% | 811.6K shares |
819.7K company shares as of Sep 3, 2026 · institutions as of Mar 31, 2026 · holders as of their latest filing
Two share counts disagree (819.7K in the company's Sep 3, 2026 report, 504.9K elsewhere); stakes use the report.
Institutions13F, as of Mar 31, 2026
26 holders · 93.5K shares · 11 new positions · 13 increased · 2 reduced · 5 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| Geode Capital Management, LLC | 33.4K | 4.07% | +33.4Knew | May 15, 2026 |
| Manchester Financial Inc | 20.0K | 2.44% | +20.0Knew | Apr 23, 2026 |
| Mayflower Financial Advisors, LLC | 20.0K | 2.44% | +20.0Knew | Apr 23, 2026 |
| Vanguard Capital Management LLC | 6.0K | 0.73% | +6.0Knew | May 15, 2026 |
| FNY Investment Advisers, LLC | 5.0K | 0.61% | +5.0Knew | Apr 15, 2026 |
| 2.2K | 0.27% | +2.2Knew | May 13, 2026 | |
| Jones Financial Companies LLLP | 2.1K | 0.26% | +1.1K | May 15, 2026 |
| Citigroup Inc | 2.0K | 0.25% | +2.0K | May 11, 2026 |
Ownership statements13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| Masaya Otsuka | 6.76% | 13G | Oct 22, 2024 ↗ | |
| Forsakringsaktiebolaget Avanza Pension | 5.00% | 13G | Oct 3, 2024 ↗ |
Insider tradesForm 4
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Apr 14, 2026 | Brent M. Longneckerdirector | Sale · 2 lots | 18 | $1.23 | 9,157 |
CongressHouse and Senate disclosures
Not reported.